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Objectives: To assess ECG changes in patients with tramadol-induced seizure(s) and compare these
changes in lower and higher than 500 mg tramadol doses as a main goal.
Material and methods: In an analytical-cross sectional manner over 1 year, 170 patients with idiosyncratic
seizure(s) after using tramadol, were studied. Full data were recorded for each patient. ECGs were taken
from all the patients on admission and 1 h later and were assessed for ﬁndings.
Results: 70 of 170 patients (41.2%) had used lower than 500 mg doses of tramadol while 90 patients
(52.9%) were included in the high dose group. Rate of female patients in the high dose group was
signiﬁcantly higher. The average age of patients in the high dose group was signiﬁcantly lower (22.04 vs
25.76). The high dose group had signiﬁcantly higher heart rates. There was no history of cardiovascular
diseases; two patients had previous history of seizure. No signiﬁcant difference was shown between low
dose and high dose groups from the point of ECG changes.
Discussion and conclusion: Using doses higher than 500 mg is more frequently seen in women, young
people and those who have not experienced previous use of tramadol. Terminal S wave, sinus tachy-
cardia, and terminal R wave in the lead aVR are among the most common ECG changes in tramadol users.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Tramadol is a synthetic analog of codeine1 with a 10-fold weaker
afﬁnity for opium receptors (resulting in analgesic effects)
compared to morphine.2 It is absorbed rapidly and almost
completely, following oral intake.3 There are also, slow-releasing
forms of tramadol in which the free portion is being released
within 12 h and the highest concentration is being achieved within
4.9 h.4 20% of tramadol gets bound to plasma proteins.5 Tramadol is
distributed in blood, kidney, and brain, but it cannot be found in
muscles. Like morphine, tramadol is signiﬁcantly accumulated in
bile rather than in kidneys and liver and its clearance takes
6 h.4 First, tramadol was claimed to be a safe agent with a low(P. Hafezi Moghadam),
om (D. Farsi), saieedabbasi@
Moﬁdi), mah_re@yahoo.com
ncy Medicine Association of
e Association of Turkey. Production
ons.org/licenses/by-nc-nd/4.0/).potential for being abused,6 but later, adverse reactions were re-
ported. Its complications are inappropriately higher in overdose.
Published cases of overdoses are mainly in an acute, oral, and
intentional setting. Majority of cases become symptomatic within
the ﬁrst 4 h and the symptoms disappear after 24 h. It is reported
that up to 20% of cases need intensive care unit (ICU) admission.
Tramadol overdose generally involves young people in third decade
of their lives, on average.7 Central nervous system complications
are the most frequently reported manifestations ranging from
agitation to deep coma.5 Seizure has been considered to have an
important role in tramadol toxicity as declared by studies and the
literature.5,7e11 Nausea/vomiting and respiratory depression have
also been reported.5,7,8 Of cardiac issues, hypotension, especially
affecting systolic blood pressure (SBP) and sinus tachycardia have
been listed as tramadol toxicity complications.5,7,8,12e14
Management of tramadol toxicity is focused on supportive care,
including oxygen, ﬂuid therapy, and diazepam for controlling
agitation or seizure.
Few studies have been conducted to investigate electrocardio-
graphic (ECG) changes after idiosyncratic seizures followingand hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
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this category of patients.
2. Material and methods
This study was conducted in an analytical cross sectional
manner since January 2013 to January 2014. The study was
approved by ethics committee of Iran University of Medical Sci-
ences (IUMS) and all ethical issues regarding researchwere fulﬁlled
during the study. Informed consent was taken from each patient or
his/her companion(s). 170 patients, admitted to a teaching Hospital
because of an idiosyncratic seizure after using tramadol, were
included in the study. Inclusion criteria were age between 16 and
80 years, complaints following tramadol abuse. Exclusion criteria
included cardiovascular disease, proof of other drugs and sub-
stances abuse with tests and use of drugs affecting cardiovascular
system before admission. A checklist including age, sex, frequency
of seizures during admission, history of seizure, and dose and
duration of tramadol use was ﬁlled. ECG was taken from all the
patients 1 h after admission. QT interval prolongation, QRS
widening, terminal S wave in the lead D1, terminal R wave in the
lead aVR, and sinus tachycardia were assessed in ECGs by trained
emergency room physician. The group of patients who had used
doses lower than 500mg of tramadol, was named “low dose” group
and patients who had used doses higher than 500 mg, were
included in the so-named “high dose” group.15e17 Acquired data
were analyzed in SPSS V.16 with independent sample t-test for
quantitative and chi-square test for qualitative comparison.
3. Results
170 patients were included in the study; In low dose group there
were 70 (41.2%) patients, including 68 men and 2 women, while 90Table 1
Basic patients' characteristics.
Low dose group High dose group p-value
Age 25.76 ± 7.30 22.04 ± 6.21 0.001
Gender 68 males (97.14%),
2 females (2.85%)
76 males (85.39%),
13 females (14.60%)
0.012
Systolic blood pressure 124 ± 14.25 120.90 ± 15.17 0.190
Diastolic blood pressure 77.94 ± 8.20 75.40 ± 10.55 0.103
Respiratory rate (RR) 23.31 ± 2.61 22.76 ± 2.61 0.106
Pulse rate (PR) 101.06 ± 20.03 92.94 ± 17.80 0.009
Fig. 1. Number of seizure epi(52.9%) of patients, including 76 men, 13 women and unknown sex
of one patient, entered the high dose group. Dose of tramadol used,
has not been recorded for 10 patients (5.9%).
There was no difference in respiratory rates (RRs) between two
groups but a signiﬁcant difference between pulse rates (PRs) of two
groups has been observed. PRs were lower in the high dose group
compared to the low dose group (92.94 ± 17.80 vs. 101.06 ± 20.03;
p ¼ 0.009) (Table 1).
There was not even one positive history of heart disease in the
participants. 157 patients denied any history of cardiac problems
and in 13 patients there was no recorded document supporting
their cardiac history. Two cases had a positive previous history of
seizure; one of them was due to previous use of tramadol.
Number of seizure attacks was 1.18 ± 0.615 and 1.26 ± 0.604 in
the low and high dose groups, respectively (p ¼ 0.169). Fig. 1 shows
the frequency of seizure attacks in patients after tramadol use.
The time interval between using tramadol and occurrence of
seizure(s) was measured in both groups. It was 150 min in the low
dose group, compared to 235 min in the high dose group; there was
no statistically signiﬁcant difference between two groups (p¼ 0.113).
The positive history of previous tramadol use was signiﬁcantly
more frequent in the low dose group (p ¼ 0.002), as 47 of patients
reported previous use of tramadol, while 21 of them denied any
history of previous use (compared to 38 and 48 patients, respec-
tively, in the high dose group).
Overall, 68 patients (42.5%) showed sinus tachycardia and 4
patients (2.4%) had sinus bradycardia; sinus tachycardia was
signiﬁcantly much more frequent in the high dose group (47 vs. 21
patients; p ¼ 0.005).
There was no statistically meaningful difference between two
groups from the point of bradycardia (3 patients in the high dose
group vs. just 1 patient in the low dose group; p ¼ 0.632).
The most frequent ECG changes were terminal S wave, sinus
tachycardia, terminal R wave in the lead aVR, T wave inversion,
right bundle branch block (RBBB), and QRS widening, respectively.
No left bundle branch block (LBBB), QT interval prolongation
(Fig. 2), second or third degree atrio-ventricular (AV) block were
seen. Table 2 demonstrates ECG changes in details.
4. Discussion
Seizure is a critical issue in tramadol toxicity. While population-
based reports speculate the frequency of seizure from 8 to 14%,5,7
hospital reports declare a higher risk for seizure, from 15 tosodes in the individuals.
Fig. 2. One of patients ECG demonstrating sinus tachycardia and QT prolongation
(Corrected QT is about 0.50 msec).
Table 2
ECG changes in the patients.
ECG changes Low dose
groups
High dose
group
Total p-value
Terminal S Present 53 61 114 0.271
Absent 17 29 46
Terminal R in aVR Present 19 36 55 0.089
Absent 51 54 105
ST depression Present 2 2 4 0.799
Absent 68 88 156
T inversion Present 6 14 20 0.185
Absent 64 76 140
RBBB Present 5 12 17 0.207
Absent 65 78 143
QRS widening Present 5 6 11 0.906
Absent 65 84 149
AV Block Type I Present 0 1 1 0.376
Absent 70 89 159
Sinus Tachycardia Present 21 47 68 0.005
Absent 49 43 92
Sinus Bradycardia Present 1 2 3 0.632
Absent 69 88 157
ECG: electrocardiography, RBBB: right bundle branch block, AV: atrio-ventricular.
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higher than therapeutic ranges or in combination with antide-
pressants10; it has not been reported after standard and appro-
priate doses. More than half of tramadol abusers (54%) have
experienced at least one episode of tonic-clonic seizure in a 3-year
follow-up period.11 Different amounts have been mentioned in
various studies as the minimum dose of tramadol needed to cause
seizure, ranges from 200 mg7e350 mg8 and even higher. In our
study, 9 patients had used 100 mg of tramadol and it was the least
dose used by our cases.
The average age of people experiencing tramadol overdose, is
around 30 years according to different studies, which is consistentwith our ﬁndings. The average age of patients was 23.69 years in
our study. Different studies have reported the average interval of
seizure occurrence after using tramadol to be 4 h which was almost
the same (3.26 h) in our study.5,18
In our study which was done among patients with tramadol
toxicity and seizure, number of men was signiﬁcantly higher than
the women, but association of women with doses higher than
500 mg was stronger. Maybe the reason is that men usually abuse
Tramadol as substance but women abuse it to commit suicide. It has
been reported in previous studies that tramadol toxicity in non-
hospital setting is a little bit higher in women than men, but it's
not true for in-hospital setting.8,9
Hypotension, especially affecting SBP and sinus tachycardia are
the cardiac complications5,7 resembling ﬁndings caused by other
opioids. Inmajority of toxicities, no arrhythmiawas reported except
to tachycardia.8 There are a few case reports of Brugada ECG
pattern, right-sided heart failure (HF), refractory shock, and
asystole.12e14 Interestingly, hypertension is seen in some cases.5 As
said before, higher HRs and sinus tachycardia were seen in high
dose group and no hypotension or any considerable ECG changes or
arrhythmias were found. One study showed an association be-
tween seizure and male gender, chronic use, intentional use, and
tachycardia,18 but other studies didn't support it. In one recent
study, the most common types of ECG changes were sinus tachy-
cardia, a deep S wave in leads I and aVL, right axis deviation, and
long QTc interval, respectively. Brugada pattern and sinus brady-
cardiawere rarely presented.19 As in our study, most of studies have
not reported any arrhythmia beyond tachycardia or any serious
cardiovascular toxicity. Overall, abnormal R or S waves were not
seen in the aVR. There are just one or two case reports of serious
abnormalities like Brugada pattern, acute right-sided HF, refractory
shock, and asystole. We didn't observe any case of hypertension,
although it was reported in some studies.
We showed people who have not used tramadol before, are
more likely to use higher doses in cases of overdose in comparison
to those who have experienced it, before; this could be due to the
cautions taken by experienced users of tramadol.5. Limitations
We faced some limitations in our study including the unknown
dose of tramadol used in some patients, inability to follow-up the
patients who were transferred to ICU or left the hospital, incom-
plete data in some patients, and unawareness of concomitant drugs
used in some cases.6. Conclusion
Using doses higher than 500 mg was seen signiﬁcantly more
frequent in women, young people, and those who had not previ-
ously used tramadol. Terminal S wave, sinus tachycardia, and ter-
minal R wave in the lead aVR are among the most common ECG
changes seen in tramadol users. It is important to consider above-
mentioned ﬁndings in addition to drug history in the young pa-
tients who are admitted with seizure(s) following tramadol use.References
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